Here's why Pryiltamide "failed" phase 3 trials and marketed as a cosmetic
    Chat 9/6/2024

    At a glance
    In this educational post, the primary subjects mentioned are
    💧 KX-826 (topical) 0.5%
    💧 Minoxidil (topical)
    the tone is 😐 neutral with varies from person to person results.

    Other terms

    KX-826 failed Phase III trials due to high placebo effects, patient compliance issues, COVID-19 side effects, and detection method deviations. KX-826 is now marketed as a cosmetic and approved for combination with Minoxidil.
    View this post in the Community →

    Similar Community Posts Join

    5 / 857 results

      community Why so much hate for PP405 all of a sudden?

      in Technology  43 upvotes 4 weeks ago
      PP405 is a new hair loss treatment facing mixed reactions due to initial hype and insufficient data. Some are hopeful, but many doubt its effectiveness compared to minoxidil and finasteride.

      community Received Kintor’s KX-826 Today

      in Product  84 upvotes 1 year ago
      A user received Kintor’s KX-826/Pyrilutamide and shared initial impressions, noting concerns about the product's labeling and marketing. Other users discussed the legitimacy of the product, its effectiveness, and compared it to other treatments like Minoxidil and Finasteride.

      community To everyone who cant use FIN and doesnt want to use RU

      in Treatment  33 upvotes 1 year ago
      A new hair loss treatment, KX-826, is being discussed as a stronger and safer alternative to RU58841 and finasteride. Opinions are mixed, with some users skeptical about its effectiveness and others considering it as part of their regimen.

    Related Research

    6 / 12 results